The stock market had an interesting day today with the indices down in the morning, up midday, and rallying right to within an hour of the close, but could not get through the highs, and then a sharp sell-off ensured. They did hold secondary support, came back very sharply, and finished near the highs for the day.

Net on the day, the Dow was down 32.67 at 20,943.11, about 58 points off the low. The S&P 500 was up 2.71 at 2399.63, a penny from its high. The Nasdaq 100 reached a new closing all-time high, up 3.37 at 5681.68.

Advance-declines were 2 to 1 positive on the New York Stock Exchange, and 350 issues positive on the Nasdaq. Up/down volume was almost 3 to 1 positive on New York, total volume of 3.4 billion shares traded. The Nasdaq traded 2 billion shares and had a 4 to 3 positive volume ratio.

TheTechTrader.com board was very mixed. There were some gainers, but Priceline.com (PCLN) was a big loser today, down 86.36 to 1824.77, and really hurt the Nasdaq 100 today. Alphabet Inc. (GOOG) was down 3.39 to 928.78, Apple Inc. (AAPL) down 73 cents to 153.26, and Amazon.com, Inc. (AMZN) down 3.87 to 948.95. However, Netflix, Inc. (NFLX) gained 2.82 to 160.28.

Baidu, Inc. (BIDU) popped 59 cents to 183.57, First Solar, Inc. (FSLR) advanced 79 cents to 36.57, and Facebook, Inc. (FB) fell 19 cents to 150.29.

Tesla Motors, Inc. (TSLA) advanced nearly 4.00, up 3.96 to 325.22.

Biotech’s had a mixed session today. bluebird bio, Inc. (BLUE) was up 1.50 to 90.45, Kite Pharma, Inc. (KITE) up 2.88 to 74.98, Nektar Therapeutics (NKTR) up 1.43 to 18.97, but Supernus Pharmaceuticals, Inc. (SUPN) was down 1.00 to 31.90.

Other stocks to the upside included Mazor Robotics Ltd. (MZOR), gaining 2.01 to 42.00, Shopify Inc. (SHOP) advancing 3.91 to 93.06.

Checking TheTechTrader.com percent-gain leaderboard, low-priced Medical Transcription Billing Corp. (MTBC) bounced 45 cents, or 23%, to 2.41, on nearly 20 million shares traded, reaching as high as 3.80 earlier in the day.

Array BioPharma Inc. (ARRY) closed up 1.41, or 20%, to 8.43, on 17 million shares traded. Crocs, Inc. (CROX) thrust 1.08, or 17%, to 7.28, on 7.3 million shares traded.

Calithera Biosciences, Inc. (CALA) bounced 1.95, or 17%, to 13.25, on nearly a million shares traded. Natera, Inc. (NTRA) ran 1.51, or 16%, to 10.67, on a million shares traded.

NVIDIA Corporation (NVDA), on great earnings, exploded 18.35, or 18%, to 121.29, on 54 million shares traded.

Stepping back and reviewing the hourly chart patterns, the indices were down at the opening, back up midday, and sold off sharply in the last hour, but came all the way back to the highs for the day.

It was a good session today, in general.

Good Trading!

Harry

For more of Harry Boxer, sign up for a FREE 7-Day Trial to his Real-Time Technical Trading Diary.

(c) 2017 AdviceTrade, Inc. All rights reserved. Distributed only by written permission of AdviceTrade and The Technical Trader at info@advicetrade.com . In using any portion of Harry Boxer's content, you agree to the terms and conditions governing the use of the service as described in our disclaimer at http://www.thetechtrader.com

Mr. Boxer's commentaries and index analysis represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Trades mentioned on the site are hypothetical, not actual, positions.

Harry Boxer Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.